| インド | トルコ | オーストリア | |
| 骨切除術 | から $5,200 | から $8,000 | から $25,000 |
| 陽子線治療 | から $25,000 | から $70,000 | から $80,000 |
| 陽子線治療 | から $35,000 | から $30,000 | から $80,000 |
| 乳癌化学療法 | から $3,500 | から $1,200 | から $15,000 |
| 乳がんに対する陽子線治療 | から $26,000 | から $30,000 | から $55,000 |
Bookimedは軟骨肉腫治療価格に追加料金を加算しません。料金はクリニックの公式価格表から来ています。国に到着時にクリニックで治療代を直接お支払いいただきます。
Bookimedはお客様の安全に取り組んでいます。軟骨肉腫治療で高い国際基準を維持し、世界中の国際患者サービスに必要なライセンスを有する医療機関とのみ協力しています。
Bookimedは無料専門サポートを提供します。専属医療コーディネーターが治療前、治療中、治療後にサポートし、あらゆる問題を解決します。軟骨肉腫治療の旅路でお一人になることはありません。
この医師は、高度な技術を持つ腫瘍専門医であり、固形腫瘍、小児腫瘍、血液悪性腫瘍を含むさまざまな癌の治療を専門としています。彼女は、ウィップル手術などの保守的および外科的治療の両方に精通しています。<\/p>
彼女はLady Hardinge Medical CollegeでMBBSを取得し、Maulana Azad Medical Collegeで内科のMDを取得しました。その後、Tata Memorial HospitalでDM医療腫瘍学を追求し、そこでコンサルタントとしても勤務しました。<\/p>
彼女は国際的および国内の腫瘍学会に所属しており、肺、乳房、婦人科、泌尿生殖器の癌に関する専門知識を持ち、免疫療法とメトロノミック療法に特に関心を持っています。<\/p>
医師はムンバイのTata Memorial Hospitalで外科腫瘍学の訓練を受け、エディンバラのRoyal College of SurgeonsでMRCSを修了しました。2000年に実践を開始し、2007年にCurie Manavata Cancer Centreを設立しました。19年の経験を持ち、医師は50,000件以上の癌手術を行い、200以上の臨床試験に参加しました。医師は多くの国際的および国内の出版物を持つ著者です。乳房および胸部外科腫瘍学を専門とし、医師はMUHSでDNB Superspecialty Surgical OncologyおよびBreast Surgeryの教授です。<\/p>
この医師は、HCG Manavata Cancer Centreで12年間の経験を持つ熟練した核医学専門医です。医師は、さまざまな核スキャン、PET-CTスキャン、および核心臓病学サービスを専門としており、放射性ヨウ素およびLu-177 RN療法において熟練しています。キャリアの中で、医師は30,000件以上のPETスキャンを管理し、1,000人以上の甲状腺癌患者を治療してきました。さらに、医師はさまざまな医学雑誌に論文を発表することで、この分野に貢献しています。
Surgical resection remains the primary treatment for chondrosarcoma in Indian hospitals. Local facilities prioritize wide excision to remove the tumor and healthy margins. This type of cancer is typically resistant to traditional chemotherapy and radiation. Surgery ensures the complete physical removal of malignant cells.
Bookimed Expert Insight: Patient volume at Indian oncology centers correlates with specialized outcomes. Manipal Hospitals serves 2,000,000 patients annually. Medanta Hospital manages 20,000 patients per year. These high-capacity institutions provide multispecialty teams necessary for complex sarcoma reconstructions. Choose facilities with dedicated orthopedic oncology units for higher procedural success.
Patient Consensus: Patients emphasize the need for a dedicated sarcoma team rather than general orthopedics. Many note that traveling to tertiary hospitals in metro cities ensures access to specialists who have performed thousands of cancer-specific surgeries.
Limb preservation is highly viable in India for chondrosarcoma patients. Surgeons successfully save the limb in most cases using advanced bone resection and reconstruction. Facilities like Dr. Rela Institute utilize linear accelerators with 1 mm accuracy to target tumors while sparing healthy tissue.
Bookimed Expert Insight: Data shows that Indian centers like HCG Manavata Cancer Centre and Manipal Hospitals function as high-volume hubs. HCG Manavata alone serves over 75,000 patients annually. This massive scale allows specialists to manage rare cases of chondrosarcoma with high proficiency. Patients should look for doctors like Dr. Raj Nagarkar who have performed over 50,000 procedures. This level of experience is a critical factor in successful limb reconstruction.
Chemotherapy and radiation are secondary treatments for Indian patients with chondrosarcoma. Indian oncology teams utilize them for aggressive mesenchymal and dedifferentiated subtypes. Doctors also apply these therapies for inoperable tumors in the skull base or spine. Surgery remains the primary curative approach.
Bookimed Expert Insight: Indian oncology centers like HCG Manavata and Dr. Rela Institute prioritize high-precision diagnostics before selecting systemic therapy. Data shows centers utilizing PET-CT and IBM Watson for treatment selection process over 75,000 oncology patients annually. This heavy volume allows specialists to refine protocols for rare mesenchymal cases that mimic Ewing’s sarcoma.
Patient Consensus: Patients note it is important to confirm the exact pathology grade before starting chemo. Many emphasize getting a second opinion at a specialized sarcoma center for pelvic or spinal tumors.
India offers advanced care for Chondrosarcoma at specialized oncology centers. Leading facilities like Global Hospital Chennai and HCG Manavata Cancer Centre provide limb-salvage surgeries and proton-beam therapy. These centers utilize multidisciplinary teams and National Accreditation Board for Hospitals (NABH) standards to ensure precise surgical margins.
Bookimed Expert Insight: While many choose famous hubs, HCG Manavata Cancer Centre in Nashik serves 75,000 patients annually. Their specialists, like Dr. Raj Nagarkar, bring expertise from Tata Memorial Hospital. This high patient volume often results in more specialized experience with rare bone sarcomas than generic oncology departments.
Patient Consensus: Patients emphasize that the surgeon's ability to perform wide resections is more critical than the hospital's reputation. They also note that getting a second pathology opinion is vital because these rare tumors are sometimes misidentified.
Leading chondrosarcoma specialists in India include highly trained orthopedic oncologists specializing in complex bone tumor resections. Key experts such as Dr. Raj Nagarkar treat aggressive skeletal malignancies within JCI and NABH-accredited facilities. These specialists focus on limb-salvage surgery and comprehensive sarcoma management.
Bookimed Expert Insight: Data shows that choosing a specialist like Dr. Raj Nagarkar at HCG Manavata Cancer Centre provides an advantage in surgical experience. He has performed approximately 50,000 procedures. This high volume is critical for rare bone cancers where surgical precision directly impacts long-term survival rates.
Patient Consensus: Patients emphasize finding surgeons who regularly treat bone sarcomas rather than general oncology. They note that biopsy planning and second pathology reviews are vital for accurate grading.
Medical tourists should plan a 21 to 35 day stay in India for chondrosarcoma surgery. This timeline covers pre-operative staging, specialized tumor resection, and critical wound monitoring. You must remain locally until the surgeon confirms you are fit to fly safely to prevent complications.
Bookimed Expert Insight: Data from top Indian centers like HCG Manavata and Global Hospital suggests surgeon volume is a key safety indicator. Dr. Raj Nagarkar has performed over 50,000 surgeries, while Dr. Raja Sundaram has completed 15,000. Choosing high-volume experts often speeds the discharge process because they use advanced techniques to minimize tissue trauma.
Patient Consensus: Patients note that pathology results can delay departure. They emphasize waiting for the final wound check and surgeon clearance before booking return flights to ensure travel safety.
Major Indian hospitals offer extensive travel and visa assistance for international patients through specialized service departments. These facilities provide mandatory medical invitation letters. They also coordinate private airport transfers and hotel stays for families. Professional interpreters are typically available for non-English speakers.
Bookimed Expert Insight: While many search for logistics, the real value lies in matching specialized care with travel support. For chondrosarcoma, HCG Manavata Cancer Centre is a standout because it integrates orthopedic oncology with a dedicated research center. Having treated over 100,000 patients globally, their high volume ensures the international desk is deeply experienced with complex visa extensions. Choosing a center like this, which combines sarcoma expertise with high-capacity infrastructure, often leads to smoother administrative and clinical transitions.
Patient Consensus: Patients note that while hospitals provide the necessary invitation letters, you must still manage the formal visa application yourself. They emphasize sending all pathology reports for remote review before traveling to ensure the surgeon confirms your case is treatable.